AstraZeneca, Zydus Reach Deal To End Nexium IP Suit
AstraZeneca AB and Zydus Pharmaceuticals USA Inc., an American subsidiary of Indian drugmaker Zydus Cadila, have settled a New Jersey federal lawsuit alleging that Zydus' plans to manufacture generic versions of...To view the full article, register now.
Already a subscriber? Click here to view full article